CompletedPHASE1, PHASE2NCT00808704

Neurological Outcome After Erythropoietin Treatment for Neonatal Encephalopathy

Studying Neonatal hypoxic and ischemic brain injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Zhengzhou University
Principal Investigator
Changlian Zhu, MD, PhD, D.C
Zhengzhou University
Intervention
recombinant human erythropoietin(drug)
Enrollment
167 enrolled
Eligibility
All sexes
Timeline
20032008

Study locations (1)

Collaborators

Zhengzhou Children's Hospital, China · Medical University Innsbruck · Göteborg University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00808704 on ClinicalTrials.gov

Other trials for Neonatal hypoxic and ischemic brain injury

Additional recruiting or active studies for the same condition.

See all trials for Neonatal hypoxic and ischemic brain injury

← Back to all trials